- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/94 - Pancreatin
Patent holdings for IPC class C12N 9/94
Total number of patents in this class: 42
10-year publication summary
5
|
3
|
8
|
3
|
4
|
0
|
4
|
0
|
3
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Abbott Laboratories GmbH | 11 |
5 |
Scientific Protein Laboratories, LLC | 7 |
4 |
Nordmark Pharma GmbH | 33 |
4 |
Abbvie Inc. | 1795 |
3 |
Nordmark Arzneimittel GmbH & Co. KG | 8 |
3 |
Solvay Pharmaceuticals GmbH | 28 |
3 |
Abbott Products GmbH | 9 |
2 |
Henkel AG & Co. KGaA | 10424 |
2 |
Abbott GmbH & Co. KG | 131 |
2 |
Allergan Pharmaceuticals International Limited | 220 |
2 |
Aptalis Pharma Limited | 12 |
2 |
Kashiv Biosciences, LLC | 83 |
2 |
Allergan Pharmaceuticals International Limited | 3 |
2 |
Société des Produits Nestlé S.A. | 9168 |
1 |
Saint Louis University | 300 |
1 |
University of Newcastle upon Tyne | 245 |
1 |
America Great Health | 8 |
1 |
Perseo Pharma AG | 13 |
1 |
Aelius Biotech Limited | 4 |
1 |
Other owners | 0 |